Carbamazepine increases atherogenic lipoproteins: Mechanism of action in male adults

American Journal of Physiology - Heart and Circulatory Physiology

Volumn 282, Issue 2 51-2, 2002, Pages

  Brämswig, Susanne ^a   Kerksiek, Anja ^a   Sudhop, Thomas ^a   Luers, Claus ^a   Von Bergmann, Klaus ^a   Berthold, Heiner K ^a  

^a Ctr for Cardiovasc Dis Rotenburg   (Germany)

Author keywords

Apolipoproteins; Cholesterol; Stable isotopes

Indexed keywords

APOLIPOPROTEIN B; CAMPESTEROL; CARBAMAZEPINE; CHOLESTANOL; CHOLESTEROL; HIGH DENSITY LIPOPROTEIN; INTERMEDIATE DENSITY LIPOPROTEIN; LATHOSTEROL; LIPOPROTEIN; LOW DENSITY LIPOPROTEIN; MEVALONIC ACID; SITOSTEROL; STEROL; THYROID HORMONE; TRIACYLGLYCEROL; VERY LOW DENSITY LIPOPROTEIN;

ADULT; ARTICLE; ATHEROGENESIS; CATABOLISM; CHOLESTEROL SYNTHESIS; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN EXPERIMENT; INTESTINE ABSORPTION; ISOTOPE LABELING; LIPID METABOLISM; LIPOPROTEIN METABOLISM; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0036084802     PISSN: 03636135     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpheart.00580.2001     Document Type: Article

References (54)

1. Thyroxine inversely regulates serum intermediate density lipoprotein levels in children with congenital hypothyroidism
2. HDL metabolism and atherosclerosis
3. Serum lipids and anticonvulsants
4. Isotopic evidence for the differential regulation of arginine and proline synthesis in man
5. Correlation between serum levels of some cholesterol precursors and activity of HMG-CoA reductase in human liver
6. Carbamazepine-induced increases in total serum cholesterol: Clinical and theoretical implications
7. Rapid method for the isolation of lipoproteins from human serum by precipitation with polyanions
8. Serum lipids, lipoproteins and apolipoproteins A and B in epileptic patients treated with valproic acid, carbamazepine or phenorbital
9. Incidence of coronary heart disease and lipoprotein levels
10. Models to interpret kinetic data in stable isotope tracer studies
11. Changes in circulating androgens during short term carbamazepine therapy
12. Changes in circulating thyroid hormones during short-term hepatic enzyme induction with carbamazepine
13. Isopropanol precipitation method for the determination of apolipoprotein B specific activity and plasma concentrations during metabolic studies of very low density lipoprotein and low density lipoprotein apolipoprotein B
14. Effects of long-term treatment with antiepileptic drugs on serum lipid levels in children with epilepsy
15. Epileptikkojen kuolleisuus Suomessa vuosina 1967-1973
16. Total cholesterol, high-density lipoprotein cholesterol, and triglycerides in children receiving antiepilieptic drugs
17. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge
18. Effect of ketoconazole on cholesterol precursors and low density lipoprotein kinetics in hypercholesterolemia
19. The effect of chronic anticonvulsant therapy on serum lipids and lipoproteins in epileptic children
20. Serum lipids in epileptic patients receiving carbamazepine: Effect of age, sex and serum concentration
21. Serum lipid levels during carbamazepine medication: A prospective study
22. Liver enzyme induction and serum lipid levels after replacement of carbamazepine with oxacarbazepine
23. Serum lathosterol concentration is an indicator of whole-body cholesterol synthesis in humans
24. Human liver carbamazepine metabolism: Role of CYP3A4 and CYP2C8 ind 10,11-epoxide formation
25. Urinary excretion of meva-Ionic acid as an indicator of cholesterol synthesis
26. Effect of thyroid hormone on plasma apolipoproteins and ApoA- and ApoB-containing lipoprotein particles
27. Phenytoin and serum cholesterol
28. Microsomal enzyme induction, lipoproteins and atherosclerosis
29. Plasma high-density lipoprotein cholesterol in epileptics treated with various anticonvulsants
30. High-density lipoproteins and hepatic microsomal enzyme induction in alcohol consumers
31. Plasma high density lipoprotein cholesterol and hepatic cytochrome P-450 concentrations in epileptics undergoing anticonvulsant treatment
32. Serum low-density lipoprotein and high-density lipoprotein cholesterol, and liver size in subjects on drugs inducing hepatic microsomal enzymes
33. Serum plant sterols and cholesterol precursors reflect cholesterol absorption and synthesis in volunteers of a randomly selected male population
34. Mortality from ischaemic heart disease among patients using anticonvulsive drugs: A case-control study
35. Effects of enzyme induction on plasma lipids using antipyrine, phenobarbital, and rifampicin
36. Serum elevation of high density lipoprotein (HDL) cholesterol in epileptic patients taking carbamazepine or phenytoin
37. Thyroid replacement therapy and its influence on postheparin plasma lipases and apolipoprotein-B metabolism in hypothyroidism
38. Plasma mevalonate as a measure of cholesterol synthesis in man
39. A comparative study of the relative enzyme inducing properties of anticonvulsant drugs in epileptic patients
40. A preliminary model for human lipoprotein metabolism in hyperlipoproteinemia
41. The effect of enzyme induction on the cytochrome P450-mediated bioactivation of carbamazepine by mouse liver microsomes
42. Serum lipids, lipoproteins and apolipoproteins in adult epileptic patients treated with carbamazepine, valproic acid or phenytoin
43. Effect of anticonvulsant drugs on plasma total cholesterol, high-density lipoprotein cholesterol, and apolipoproteins A and B in children with epilepsy
44. Direct association between the hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 and plasma mevalonic acid and lathosterol concentrations in man
45. Hepatic secretion of very-low-density lipoprotein apolipoprotein B-100 studied with a stable isotope technique in men with visceral obesity
46. Serum lipids in epileptic children treated with carbamazepine and valproate
47. Increased high-density lipoprotein cholesterol in patients with epilepsy treated with carbamazepine: A gender-related study
48. Carbamazepine induces multiple cytochrome P450 subfamilies in rats
49. Hepatic overexpression of microsomal triglyceride transfer protein (MTP) results in increased in vivo secretion of VLDL triglycerides and apolipoprotein B
50. Thyroid status of patients receiving long-term anticonvulsant therapy assessed by peripheral parameters: A placebo-comtrolled thyroxine therapy trial
51. Changes in serum lipids and lipoproteins in epileptic children treated with anticonvulsants
52. Direct correlation between cholesterol synthesis and hepatic secretion of apolipoprotein B-100 in normolipidemic subjects
53. The effects of long-term anticonvulsive treatment on serum lipid profile
54. Changes of serum lipid patterns during long-term anticonvulsive treatment